A systematic review on the potential use of machine learning to classify major depressive disorder from healthy controls using resting state fMRI measures

Background: Major Depressive Disorder (MDD) is a psychiatric disorder characterized by functional brain deficits, as documented by resting-state functional magnetic resonance imaging (rs-fMRI) studies.Aims: In recent years, some studies used machine learning (ML) approaches, based on rs-fMRI features, for classifying MDD from healthy controls (HC). In this context, this review aims to provide a comprehensive overview of the results of these studies.Design: The studies research was performed on 3 online databases, examining English-written articles published before August 5, 2022, that performed a two-class ML classification using rs-fMRI features. The search resulted in 20 eligible studies.Results: The reviewed studies showed good performance metrics, with better performance achieved when the dataset was restricted to a more homogeneous group in terms of disease severity. Regions within the default mode network, salience network, and central executive network were reported as the most important features in the classification algorithms. Limitations: The small sample size together with the methodological and clinical heterogeneity limited the generalizability of the findings.Conclusions: In conclusion, ML applied to rs-fMRI features can be a valid approach to classify MDD and HC subjects and to discover features that can be used for additional investigation of the pathophysiology of the disease.

Automated summary

In recent years, machine learning approaches based on rs-fMRI features have been used to classify MDD and HC subjects. This review provides a comprehensive overview of these studies, finding that better classification performance was achieved when the dataset was more homogeneous in terms of disease severity. Regions within the default mode network, salience network, and central executive network were identified as the most important features in the classification algorithms. However, the limited sample size and methodological and clinical heterogeneity restrict the generalizability of the findings. Machine learning applied to rs-fMRI features can effectively classify MDD and HC subjects and discover features for further investigation of the disease's pathophysiology.